Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Felice Vito Vitale"'
Publikováno v:
SAGE Open Medicine, Vol 5 (2017)
A systemic activation of blood coagulation is usually present in many clinical conditions including the infectious or inflammatory ones and malignant disease as well. Depending upon circumstances, patients suffering from acute decompensated dissemina
Externí odkaz:
https://doaj.org/article/858a4551098e47b69ee5fbe17d072cc7
Autor:
Giovanna Antonelli, Giuseppe Grasso, Francesco Ferraù, Michele La Greca, Salvatore Bartolotta, Alessandro D'Angelo, Felice Vito Vitale, Alessia Erika Russo
Publikováno v:
OncoTargets and therapy
Neoadjuvant chemotherapy has been successfully tested in several bulky solid tumors, but it has not been utilized in advanced cutaneous melanoma, primarily because effec- tive medical treatments for this disease have been lacking. However, with the d
Autor:
Francesco Ferraù, Massimo Libra, Paolo Colina, Alessia Russo, Giovanna Antonelli, Vincenzo Panebianco, Felice Vito Vitale, Alessandro D'Angelo, Rosalba Rossello
Lung cancer is the most common cause of cancer-related mortality in men and women. Non-small cell lung cancer (NSCLC) represents close to 90% of all lung cancers. When diagnosed, >50% of patients are >65 years old. Through an improved understanding o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::278421d93be144acd90e2122db6b801b
http://hdl.handle.net/20.500.11769/34515
http://hdl.handle.net/20.500.11769/34515
Autor:
Alessandra Parisi, Valentina Giaimo, Giovanna Antonelli, Placido Romeo, Stefano Rotondo, Alessandro D'Angelo, Felice Vito Vitale, Edoardo Sessa, Francesco Ferraù
Publikováno v:
Journal of Oncology Pharmacy Practice. 18:10-16
Background. Venous thromboembolism (VTE) and brain metastases (MTS) are significant clinical problems in the cancer patient population. Brain MTS and deep vein thrombosis are life-threatening conditions because of the risk of fatal endocranic hyperte
Publikováno v:
SAGE Open Medicine, Vol 5 (2017)
SAGE Open Medicine
SAGE Open Medicine
A systemic activation of blood coagulation is usually present in many clinical conditions including the infectious or inflammatory ones and malignant disease as well. Depending upon circumstances, patients suffering from acute decompensated dissemina
Autor:
Paolo Colina, Francesco Ferraù, Felice Vito Vitale, Bruno Luciani, Mario Raffaele, Placido Romeo
Publikováno v:
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners. 21(5)
Ampullary carcinoma is an uncommon gastrointestinal disease. Its natural history is often characterized by the occurrence of liver metastases. Among patients who undergo pancreatoduodenectomy, those presenting with lymph nodes involvement are more pr
Autor:
Francesco Ferraù, Stefania Calì, Emilia Malaponte, Vincenzo Panebianco, Felice Vito Vitale, Rosario Blandino, Giovanna Antonelli
Publikováno v:
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners. 19(3)
Background: Mitomycin and irinotecan are widely used in the treatment of colorectal cancer, furthermore both of these drugs are active agents against nonsmall cell lung cancer and their combination has shown synergism in preclinical studies. The aim
Autor:
Felice Vito, Vitale, Placido, Romeo, Enrico Maria, DI Maggio, Alessandra, Parisi, Emilia, Malaponte, Stefania, Calì, Fabio, Vasta, Vincenzo, Panebianco, Domenico, Arcoria, Francesco, Ferraù
Publikováno v:
Anticancer research. 31(12)
Locoregional treatments represent a good option for patients suffering from hepatocellular carcinoma (HCC) not eligible for resection or transplantation. Locoregional approaches include a wide spectrum of therapeutic methods and hepatic intra-arteria
Autor:
Felice Vito, Vitale, Placido, Romeo, Fabio, Vasta, Vincenzo, Panebianco, Stefania, Calì, Stefano, Rotondo, Francesco, Ferraù, Michele, La Greca
Publikováno v:
Anticancer research. 27(6B)
Surgery (partial hepatic resection or orthotopic liver transplantation) remains the mainstay for treatment of hepatocellular carcinoma (HCC). Unfortunately, most patients have HCC that cannot be removed either as a result of its size, multiple tumors
Autor:
E. Sessa, Stefano Rotondo, Felice Vito Vitale, Francesco Ferraù, A. Parisi, Giovanna Antonelli, V. Giaimo
Publikováno v:
Thrombosis Research. 125:S185